false
0001961847
0001961847
2025-11-13
2025-11-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): November
13, 2025
INNO
HOLDINGS INC.
(Exact
name of registrant as specified in its charter)
| Texas |
|
001-41882 |
|
87-4294543 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
ID
No.) |
RM1,
5/F, No. 43 Hung To Road
Kwun
Tong, Kowloon, Hong Kong |
|
999077 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
(800)
909-8800
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
| Common
Stock, no par value |
|
INHD |
|
The
Nasdaq Stock Market LLC |
Item
1.01 Entry into a Material Definitive Agreement.
On
November 12, 2025, Inno Holdings Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”)
with Aegis Capital Corp. (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time,
to or through the Sales Agent, shares of the Company’s common stock, with no par value, having an aggregate offering price of up
to $50.0 million (the “Placement Shares”).
The
Company is not obligated to sell any Placement Shares under the Sales Agreement. Subject to the terms and conditions of the Sales Agreement,
the Sales Agent will use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state
and federal laws, rules and regulations and the rules of The Nasdaq Stock Market LLC (“Nasdaq”), to sell Placement
Shares from time to time based upon the Company’s notice and instructions, up to the amount specified therein. Under the Sales
Agreement, the Sales Agent may sell Placement Shares by any method permitted by law deemed to be an “at the market offering”
as defined in Rule 415(a)(4) under the Securities Act of 1933, including sales made directly on Nasdaq or on any other existing trading
market or directly to the Sales Agent as principal in negotiated transactions. The Sales Agent may also sell Placement Shares by any
other method permitted by law, including in privately negotiated transactions, with the Company’s consent.
In
accordance with the Sales Agreement, the Company will pay the Sales Agent in cash, upon each sale of Placement Shares pursuant
to the Sales Agreement, an amount equal to three percent (3.0%) of the gross proceeds from each sale of Placement Shares. The Sales Agreement
may be terminated by the Company and the Sales Agent at any time upon notice to the other party. If not terminated earlier, the Sales
Agreement will automatically terminate upon the earlier to occur of (i) May 12, 2026 (the sixth month anniversary of the date
of the Sales Agreement), or (ii) the issuance and sale of all of the Placement Shares under the Sales
Agreement.
The “at the market”
offering is being made pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-284054), which
was filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 26, 2024 and declared effective
by the SEC on January 10, 2025, the base prospectus contained therein, and the prospectus
supplement dated November 13, 2025 filed with the SEC on November 13, 2025.
The foregoing summaries
of the Sales Agreement do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the
Sales Agreement, which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated by reference
herein.
McCarter & English,
LLP, counsel to the Company, has delivered its opinion as to the legality of the issuance and sale of the Placement Shares, a
copy of which is filed as Exhibit 5.1 to this Current Report on Form 8-K.
Item
7.01 Regulation FD Disclosure
On
November 13, 2025, the Company issued a press release announcing entry into the Sales Agreement, pursuant to which the Company
may offer and sell, from time to time, through the Sales Agent, Placement Shares having an aggregate offering price of up to $50.0 million.
A copy of the press release is attached as Exhibit 99.1 to this report.
The
information in Item 7.01 and Exhibit 99.1 is being “furnished” and shall not be deemed “filed” for the purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, is not subject to the liabilities of that section and is not deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended,
except as shall be expressly set forth by specific reference in such a filing.
This
Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any Placement Shares under the
Sales Agreement nor shall there be any sale of such Placement Shares in any state in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of any such state.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
| Exhibit
No. |
|
Description |
| 1.1 |
|
Sales Agreement, dated November 12, 2025, by and between Inno Holdings Inc. and Aegis Capital Corp. |
| 5.1 |
|
Opinion of McCarter & English, LLP |
| 23.1 |
|
Consent of McCarter & English, LLP (included in Exhibit 5.1) |
| 99.1 |
|
Press Release, dated November 13, 2025 |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
| |
INNO
HOLDINGS Inc. |
| |
|
|
| Date:
November 13, 2025 |
By: |
/s/
Ding Wei |
| |
Name: |
Ding
Wei |
| |
Title: |
Chief
Executive Officer |